XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Net revenues $ 115,098 $ 104,251 $ 223,440 $ 201,816
Operating costs:        
Salaries and related costs 64,607 58,779 126,886 114,606
Rent, supplies, contract labor and other 22,168 20,033 43,944 40,120
Provision for doubtful accounts 1,151 888 2,212 1,786
Closure costs 18 17 30 23
Total operating costs 87,944 79,717 173,072 156,535
Gross Profit 27,154 24,534 50,368 45,281
Corporate office costs 10,128 8,856 20,291 17,403
Operating income 17,026 15,678 30,077 27,878
Interest and other income, net 22 23 54 47
Interest expense:        
Mandatorily redeemable non-controlling interests - change in redemption value 0 (3,923) 0 (6,592)
Mandatorily redeemable non-controlling interests - earnings allocable 0 (1,787) 0 (3,081)
Debt and other (545) (516) (1,098) (931)
Total interest expense (545) (6,226) (1,098) (10,604)
Income before taxes 16,503 9,475 29,033 17,321
Provision for income taxes 3,267 3,085 5,743 4,897
Net income 13,236 6,390 23,290 12,424
Less: net income attributable to non-controlling interests (3,990) (1,449) (6,927) (2,667)
Net income attributable to USPH shareholders $ 9,246 $ 4,941 $ 16,363 $ 9,757
Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.48 $ 0.39 $ 0.74 $ 0.78
Shares used in computation - basic and diluted (in shares) 12,677 12,579 12,647 12,553
Dividends declared per common share (in dollars per share) $ 0.23 $ 0.20 $ 0.46 $ 0.40
Net Patient Revenues [Member]        
Net revenues $ 105,989 $ 97,657 $ 206,541 $ 191,311
Other Revenues [Member]        
Net revenues $ 9,109 $ 6,594 $ 16,899 $ 10,505